Cardiovascular and renal outcomes with varying degrees of kidney disease in high-risk people with type 2 diabetes: An epidemiological analysis of data from the AMPLITUDE-O trial

Overview

cited authors

Gerstein, Hertzel C.; Mian, Rajibul; Ramasundarahettige, Chinthanie; Branch, Kelley R. H.; Del Prato, Stefano; Lam, Carolyn S. P.; Lopes, Renato D.; Pratley, Richard; Rosenstock, Julio; Sattar, Naveed

authors

Pratley, Richard Edwin, MD

Publication Date

December 20, 2023

webpage

Web of Science

published in

DIABETES OBESITY & METABOLISM Journal

Research

keywords

GLP-1 analogue
cardiovascular disease
kidney disease
randomized trial
type 2 diabetes

301 E Princeton St., Orlando, FL 32804 | FH.RAS@AdventHealth.com | 407-200-2901

The information on this website is not a substitute for examination, diagnosis, and medical care provided by a licensed and qualified health professional. Please consult your physician before undertaking any form of medical treatment and/or adopting any exercise program or dietary guidelines. If you think you may have a medical emergency, call your physician or 911 immediately. AdventHealth Research Institute reserves the right to add, remove or edit content on this page at its sole discretion.